Skip to main content
Category

News Archive

NewImage

Gene Therapy Companies in Maryland – American Gene Technologies

By News Archive

NewImage

Maryland is home to one of the largest life science clusters in the nation. According to the Maryland Department of Commerce, the State has nearly 2,300 life science companies and 476 private research and development biotechnology firms (NAICS 541714), which represents 5.3% of this U.S. industry.

Some of the nation’s most important research occurs within Maryland at National Institute of Health (NIH), Food & Drug Administration (FDA), federal laboratories, Johns Hopkins, and the University of Maryland. In fiscal year 2018, Maryland received $1.5 billion from NIH for biomedical research, behind four other states (NIH 2018 report):

Image: https://www.americangene.com

Read More

These 3 Johns Hopkins research teams got seed funding to develop their medical devices – Technical.ly

By News Archive

(L to R) Therese Canares, Mathias Unberath, Clifford Weiss and Ethan Tumarkin.

(Courtesy image)

With the Bisciotti Foundation Translational Fund, John Hopkins University School of Medicine is bringing seed funding to three teams of researchers creating innovative medical devices.

Each of these devices, which are being developed by Hopkins professors and fellows, aim to dramatically decrease costs on hospitals and improve patient care by taking anesthesia out of the equation. Recipients were awarded between $25,000 and $100,000 to conduct their work during a period of up to nine months.

Image: (L to R) Therese Canares, Mathias Unberath, Clifford Weiss and Ethan Tumarkin. (Courtesy image)

Read More
DandD

Korea-based D&D under Johns Hopkins team in spotlight for novel dementia therapy – 매일경제 영문뉴스 펄스(Pulse)

By News Archive

DandD

D&D Pharmatech, a clinical-stage global biotech company, features a strong research emphasis, with focus on neurodegenerative brain disorders led by Johns Hopkins University School of Medicine neuroscientists, including Ted M. Dawson, MD, PhD, who is a globally recognized authority in this domain.

The company’s founder Lee Seulki, PhD, 45, also working at the university as a radiology professor, is a promising medical scientist who is the youngest `Highly Cited Researcher` named by Clarivate Analytics in 2017.

 

Read More
NIH SEED BHI2

Open Position: Life Sciences Business Analyst at NIH SEED Office

By News Archive

NIH SEED BHI2BioHealth Innovation, Inc. (BHI), is a Montgomery County innovation intermediary which translates market-relevant research into commercial success by bringing together management, funding, and markets. BHI is seeking a life science business analyst to support the NIH SEED Office (https://seed.nih.gov/). The analyst will provide business landscape analysis and other project support on product development, corporate strategy, and private investment for NIH-funded companies. This will entail market landscape, technology, and other business intelligence research to support Entrepreneur-in-Residence and other SEED life science commercialization activities.

Download the PDF of the job description.

View on LinkedIn

View on Indeed

CareDx Logo

CareDx Leads the Way in Xenotransplant Organ Surveillance

By News Archive

CareDx Logo

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that its non-invasive organ transplant surveillance solutions are being used to help monitor post-operative graft health in the world’s first successful heart xenotransplantation. A genetically modified pig heart was successfully transplanted into a patient at the University of Maryland Medical Center on January 7, 2022.

 

Read More
Emergent Logo

Emergent underway with $100M in manufacturing upgrades as it gears up for ‘post-pandemic work’ | FiercePharma

By News Archive

Emergent Logo

After struggling through COVID-19 vaccine production woes in 2021, Emergent BioSolutions has another surprise for its investors in early 2022. 

Last month, Emergent projected revenues of $1.4 billion to $1.5 billion for this year. Now, the company has dropped the figure to $1.3 to $1.4 billion. 

Why the adjustment?

In its quarterly report, Emergent credited its decision to undergo maintenance on its troubled Baltimore Bayview facility “earlier than anticipated,” and to expand the project to set the facility up for “future non-pandemic work.”

 

Read More
BHI Logo

BHI’s next EIR Feedback Day is March 16th

By News Archive

BHI Logo

These free 1:1 virtual sessions are an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices. If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.

 

To sign-up for any of the EIR dates in 2022, please follow this link.

NIH BHI Logo

Opportunity: Entrepreneur-In-Residence Role with BioHealth Innovation, Inc. and NIH

By News Archive

NIH BHI LogoPOSITION DESCRIPTION – Entrepreneur-In-Residence

EIRs will work in collaboration with SEED to mentor innovators and provide guidance to help them de-risk the technical and business elements of their product development projects. EIRs will also help NIH and individual innovators ensure the long-term success of their projects by facilitating connections with investors and strategic partners who can help achieve commercial success and healthcare consumer access. To be successful in this role, entrepreneurial, commercial or product development experience in areas of social impact including wellness & prevention, healthcare access/community health and a wide network in social impact ventures is required.

This position is currently remote (with opportunity for future in-person activities) and part time (20 hrs/week with potential for expansion); occasional travel may be required (when conditions permit).

Learn more

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.